Previous Section Index Home Page

31 Mar 2009 : Column 1086W—continued

Blood: Donors

Mr. Stephen O'Brien: To ask the Secretary of State for Health pursuant to the answer of 23 February 2009, Official Report, column 199W, on blood: donation, for what reasons the units were not transfused. [267379]

Dawn Primarolo: The following table shows total red cell units issued to hospitals in England and North Wales reporting data to the Blood Stocks Management scheme which were not transfused; the percentage of units issued which were not transfused; and a breakdown of the reasons the units were not transfused in each year since 2005-06:

Financial Year Red cells issued and not transfused Total percentage red cells issued and not transfused( 1) Reason not transfused( 2) Percentage breakdown by reason of units issued and not transfused

2005-06

35,917

2.56

Time Expired

73.8

OTCOL

18.4

MISC

5.6

FF

2.2

2006-07

31,620

2.24

Time Expired

70.2

OTCOL

21.3

MISC

7.1

FF

1.4

2007-08

30,188

2.21

Time Expired

70.2

OTCOL

21.8

MISC

5.9

FF

2.1

(1 )Figures given to one decimal place in answer of 23 February 2009, Official Report, column 199W.
(2) Wastage reasons:
OTCOL-out of temperature control outside laboratory (unit failed thirty minute rule).
FF-fridge failure (physical failure of blood bank).
MISC-Miscellaneous (any other reason not covered by the other three reasons).

The figures given for the percentage of red cell units issued and not transfused for each financial year correct the information in the written answer given to the hon. Member on 23 February 2009, Official Report, column 199W.

Mr. Stephen O'Brien: To ask the Secretary of State for Health when the decision to stop supplying (a) human serum and (b) blood for non-clinical purposes was made by NHS Blood and Transplant; what consultation was undertaken before the decision; how
31 Mar 2009 : Column 1087W
much blood has been used for non-clinical purposes in each of the last 10 years; and what those purposes were. [267517]

Dawn Primarolo: No decision to stop supplying human serum or blood for non-clinical purposes has been made by NHS Blood and Transplant (NHSBT).

The provision of blood for clinical purposes always takes precedence over non-clinical issues. Blood is supplied for non-clinical use according to strict protocols. Wherever possible, blood which is not suitable for therapeutic use for patients is used for this purpose. However, where this is not possible consent is sought from donors.

The following series of tables shows blood issued by NHS Blood and Transplant for non-clinical purposes such as quality assurance; quality control; development; validation; and ethically approved research in each financial year since 2004-05. Information is not available for a complete financial year prior to 2004-05.


31 Mar 2009 : Column 1088W
Non clinical issue product Quantity (units)

Financial year 2004-05

Buffy coat residue

669

Buffy coats

4,818

Clinical Spec Research Plasma

32

Clinical Spec Research Red Cells

15

Clinical Spec Research Whole Blood

84

Research plasma—sterile 250

1,180

Research platelets

12

Research red cells

184

Research whole blood

530

Serum

346

Serum group AB

452

Serum—non AB

1,017

Time Expired Apheresis Platelets internal use only

12

Time expired Neonatal platelets

8

Time Expired Platelets

20

Financial year 2005-06

Buffy Coat Residue

2,286

Buffy coats

4,615

Clinical Spec Research Plasma

5

Clinical Spec Research Red Cells

15

Clinical Spec Research Whole Blood

166

Leukocyte Filters

179

Research Cryo Depleted Plasma

3

Research Plasma—sterile 250

1,310

Research platelets

22

Research red cells

162

Research whole blood

638

Serum group AB

261

Serum—non AB

1,508

Serum—non AB (OPC)

239

Time Expired Apheresis Platelets (internal use only)

14

Time expired platelets

19

Time expired red cells

22

Whole Blood—Filter residue

2,564

Financial year 2006-07

Buffy Coat Residue

801

Buffy coats

4,614

Clinical Spec Research Plasma

4

Clinical Spec Research Red Cells

22

Clinical Spec Research Whole Blood

194

Cryoprecipitate—internal use only

7

Leukocyte Filters

74

Research Cryo Depleted Plasma

12

Research plasma—sterile 250

1,271

Research platelets

17

Research red cells

176

Research whole blood

676

Serum

97

Serum group AB

405

Serum—non AB

1,295

Time Expired Apheresis Platelets (internal use only)

24

Time Expired Platelets

86

Time Expired red cells

7

Financial year 2007-08

Buffy Coat Residue

919

Buffy coats

4,895

Clinical Spec Research Plasma

3

Clinical Spec Research Platelets

4

Clinical Spec Research Red Cells

15

Clinical Spec Research Whole Blood

241

Leukocyte Filters

58

Research Cryo Depleted Plasma

1

Research Plasma—sterile 250

1,447

Research platelets

36

Research platelets—marginal cost

13

Research red cells

104

Research whole blood

906

Serum

277

Serum group AB

316

Serum—non AB

1,245

Time Expired Apheresis Platelets (internal use only)

1

Time expired platelets

77

Time expired red cells

57

Whole Blood filter residue

21

Financial year 2008-09 (up to 28 February 2009)

Buffy Coat Residue

693

Buffy coats

4,710

Clinical Spec Research Plasma

6

Clinical Spec Research Red Cells

16

Clinical Spec Research Whole Blood

213

Internal only—CRYO

1

Internal only—Platelets

30

Leukocyte Filters

246

Research Cryo Depleted Plasma

1

Research plasma—sterile 250

1,226

Research platelets

1

Research red cells

99

Research whole blood

766

Serum group AB

163

Serum—non AB

708

Serum—non AB—1001

128

Time Expired Platelets

95

Time expired red cells

66

Whole Blood filter residue

30


Next Section Index Home Page